Assessment of the quality of life in metastatic colorectal cancer patients with KRAS gene mutant: a case-control study.

Symptom severity Subgroup analysis found no statistically significant differences in symptom severity between the wild-type and mutant groups, except for a possible trend suggesting greater pain severity in the mutant group, which neared statistical significance ( p = 0.056) (Table 5 ).

also in 228 other papers